Differences in tumor mutation burden are a major reason for

The expected course of a patient's cancer prognosis has traditionally been judged by its type, stage and microscopic aggressiveness, but patients with the same presentation can still have widely divergent outcomes. Researchers from Vanderbilt-Ingram Cancer Center have discovered that differences in tumor mutation burden are a major reason for this divergence.

Related Keywords

Lily Ramsey , William Dupont , Jeffrey Smith , Fritz Parl , Vanderbilt Ingram Cancer Center , Drug Administration , Department Of Veterans Affairs , National Institutes Of Health , Vanderbilt University Medical Center , Study Corresponding Author , Health Policy , Preventive Medicine , Vanderbilt University Medical , Pan Cancer Atlas , National Institutes , Mutation , Humor , Dancer , Medicine , Ncology ,